Similasan Usa
Recent News About Similasan Usa View More
-
Calif. federal court rejects settlement in class action over company’s homeopathic products
The rejected settlement purported to require Similasan to make label changes and maintain a website concerning homeopathic “dilution principles.” No unnamed class members would have received any compensation under the rejected agreement, and class attorneys would have been awarded more than $500,000.